Adrenal Glands pp 251-264 | Cite as

Genetic Syndromes Associated with Adrenal Tumors

  • Göran Åkerström
  • Per Hellman


Medullary Thyroid Carcinoma Multiple Endocrine Neoplasia Type Adrenal Tumor Carney Complex SDHB Mutation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Arlt W, Callies F, van Vlijmen JC, et al. (1999) Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341:1013–1020CrossRefPubMedGoogle Scholar
  2. 2.
    Astuti D, Douglas F, Lennard TWJ, et al. (2001) Germline SDHD mutation in familial phaeochromocytoma. Lancet 357:1181–1182CrossRefPubMedGoogle Scholar
  3. 3.
    Astuti D, Latif F, Dallol A, et al. (2001) Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 69:49–54CrossRefPubMedGoogle Scholar
  4. 4.
    Baghai M, Thompson GB, Young WF, et al. (2002) Pheochromocytomas and paragangliomas in von Hippel-Lindau disease. A role for laparoscopic and cortical-sparing surgery. Arch Surg 137:682–689CrossRefPubMedGoogle Scholar
  5. 5.
    Baysal BE (2002) Hereditary paraganglioma targets diverse paraganglia. J Med Genet 39:617–622CrossRefPubMedGoogle Scholar
  6. 6.
    Baysal BE, Ferrell RE, Willett-Brozick JE, et al. (2000) Mutations in SDHD, a mitochondrial complex II gene in hereditary paraganglioma. Science 287:848–851CrossRefPubMedGoogle Scholar
  7. 7.
    Baysal BE, Rubinstein WS, Taschner PEM (2001) Phenotypic dichotomy in mitochondrial complex II genetic disorders. J Mol Med 79:495–503CrossRefPubMedGoogle Scholar
  8. 8.
    Beckwith JB (1969) Macroglossia, omphalocoele, adrenal cytomegaly, gigantism and hyperplastic visceromegaly. Birth Defects 5:188–196Google Scholar
  9. 9.
    Benn DE, Croxson MS, Tucker K, et al. (2003) Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas. Oncogene 22:1358–1364CrossRefPubMedGoogle Scholar
  10. 10.
    Brauch H, Hoppner W, Jahnig H, et al. (1997) Sporadic pheochromocytomas are rarely associated with germline mutations in the VHL tumor suppressor gene or the RET protooncogene. J Clin Endocrinol Metab 82:4101–4104CrossRefPubMedGoogle Scholar
  11. 11.
    Brunt LM, Doherty GM, Norton JA, et al. (1996) Laparoscopic adrenalectomy compared to open adrenalectomy for benign adrenal neoplasms. J Am Coll Surg 183:1–10PubMedGoogle Scholar
  12. 12.
    Brunt LM, Lairmore TC, Doherty GM, et al. (2001) Adrenalectomy for familial pheochromocytoma in the laparoscopic era. Ann Surg 235:713–721CrossRefGoogle Scholar
  13. 13.
    Burgess JR, Harle RA, Tucker P, et al. (1996) Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Arch Surg 131:699–702PubMedGoogle Scholar
  14. 14.
    Burke AP, Sobin LH, Shekitka KM, et al. (1990) Somatostatin-producing duodenal carcinoids in patients with von Recklinghausen’s neurofibromatosis. A predilection for black patients. Cancer 65:1591–1595PubMedGoogle Scholar
  15. 15.
    Cance WG, Wells SA Jr (1985) Multiple endocrine neoplasia type IIa. Curr Probl Surg 22:1–56CrossRefGoogle Scholar
  16. 16.
    Carlson KM, Dou S, Chi D, et al. (1994) Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA 91:1579–1583PubMedGoogle Scholar
  17. 17.
    Carney JA, Sizemore GW, Sheps SG (1976) Adrenal medullary disease in multiple endocrine neoplasia type 2: pheochromocytoma and its precursors. Am J Clin Pathol 66:279–290PubMedGoogle Scholar
  18. 18.
    Carney JA, Sizemore GW, Tyce GM (1975) Bilateral adrenal medullary hyperplasia in multiple endocrine neoplasia, type 2: the precursor of bilateral pheochromocytoma. Mayo Clin Proc 50:3–10PubMedGoogle Scholar
  19. 19.
    Casanova S, Rosenberg-Bourgin M, Farkas D, et al. (1993) Phaeochromocytoma in multiple endocrine neoplasia type 2A: survey of 100 cases. Clin Endocrinol 38:531–537Google Scholar
  20. 20.
    Chew SL (2001) Paraganglioma genes. Clin Endocrinol 54:573–574CrossRefGoogle Scholar
  21. 21.
    Couch V, Lindor NM, Karnes PS, et al. (2000) von Hippel-Lindau disease. Mayo Clin Proc 75:265–272PubMedGoogle Scholar
  22. 22.
    Donis-Keller H, Dou S, Chi D, et al. (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2:851–856PubMedGoogle Scholar
  23. 23.
    Easton DF, Ponder MA, Cummings T, et al. (1989) The clinical and screening age-at-onset distribution for the MEN-2 syndrome. Am J Hum Genet 44:208–215PubMedGoogle Scholar
  24. 24.
    Eisenhofer G, Lenders JW, Linehan WM, et al. (1999) Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med 340:1872–1879CrossRefPubMedGoogle Scholar
  25. 25.
    Eng C, Crossey PA, Mulligan LM, et al. (1995) Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumor suppressor gene in sporadic and syndromic pheochromocytomas. J Med Genet 32:934–937PubMedGoogle Scholar
  26. 26.
    Farndon JR, Leight GS, Dilley WG, et al. (1986) Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity. Br J Surg 73: 278–281PubMedGoogle Scholar
  27. 27.
    Friedman JM, Birch PH (1997) Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 70:138–143CrossRefPubMedGoogle Scholar
  28. 28.
    Friedrich CA (1999) Von Hippel-Lindau syndrome. A pleomorphic condition. Cancer 86:2478–2482CrossRefPubMedGoogle Scholar
  29. 29.
    Friedrich CA (2001) Genotype-phenotype correlation in von Hippel-Lindau syndrome. Hum Mol Genet 10:763–767CrossRefPubMedGoogle Scholar
  30. 30.
    Gagner M, Lacroix A, Bolte E (1992) Laparoscopic adrenalectomy in Cushing’s syndrome and pheochromocytoma. N Engl J Med 327:1033PubMedGoogle Scholar
  31. 31.
    Gimm O, Armanios M, Dziema H, et al. (2000) Somatic and occult germline mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. Cancer Res 60:6822–6825PubMedGoogle Scholar
  32. 32.
    Gutmann DH, Aylsworth A, Carey JC, et al. (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51–57PubMedGoogle Scholar
  33. 33.
    Hamilton BP, Landsberg L, Levine RJ (1978) Measurement of urinary epinephrine in screening for pheochromocytoma in multiple endocrine neoplasia type II. Am J Med 65:1027–1032CrossRefPubMedGoogle Scholar
  34. 34.
    Hansford JR, Mulligan LM (2000) Multiple endocrine neoplasia type 2 (MEN 2) and RET: from neoplasia to neurogenesis. J Med Genet 37:817–827CrossRefPubMedGoogle Scholar
  35. 35.
    Harrington JL, Farley DR, van Heerden JA, et al. (1999) Adrenal tumors and pregnancy. World J Surg 23:182–186PubMedGoogle Scholar
  36. 36.
    Henry I, Bonaiti-Pellie C, Chehensse V, et al. (1991) Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature 351:665–667CrossRefPubMedGoogle Scholar
  37. 37.
    Hofstra RM, Landsvater RM, Ceccherini I, et al. (1994) A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367:375–376CrossRefPubMedGoogle Scholar
  38. 38.
    Howe JR, Norton JA, Wells SA Jr (1993) Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long-term follow-up. Surgery 114:1070–1077PubMedGoogle Scholar
  39. 39.
    Inabnet W, Caragliano P, Pertsemlidis D (2000) Pheochromocytoma: inherited associations, bilaterality, and cortex preservation. Surgery 128:1007–1012CrossRefPubMedGoogle Scholar
  40. 40.
    Janetschek G, Finkenstedt G, Gasser R, et al. (1998) Laparoscopic partial adrenalectomy in patients with hereditary forms of pheochromocytoma. J Urol 164:14–17Google Scholar
  41. 41.
    Jhiang SM (2000) The RET protooncogene in human cancers. Oncogene 19:5590–5597CrossRefPubMedGoogle Scholar
  42. 42.
    Kapur BM, Sarin SK, Anand CS, et al. (1983) Carcinoid tumour of ampulla of Vater associated with viscero-cutaneous neurofibromatosis. Postgrad Med 59:734–735Google Scholar
  43. 43.
    Khan TS, Sundin A, Juhlin C, et al. (2003) 11C-metomidate PET imaging of adrenocortical cancer. Eur J Nucl Med Mol Imaging 30:403–410PubMedGoogle Scholar
  44. 44.
    Kikumori T, Evans D, Lee JE, et al. (2001) Genetic abnormalities in multiple endocrine neoplasia type 2. In: Doherty GM, Skogseid B (eds) Surgical endocrinology. Lippincott Williams & Wilkins, Philadelphia, pp 531–540Google Scholar
  45. 45.
    Kirschner LS, Carney JA, Pack SD, et al. (2000) Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 26:89–92CrossRefPubMedGoogle Scholar
  46. 46.
    Koch CA, Vortmeyer AO, Huang SC, et al. (2001) Genetic aspects of pheochromocytoma. Endocr Regul 35:43–52PubMedGoogle Scholar
  47. 47.
    Koch C, Mauro D, McClellan MW, et al. (2002) Pheochromocytoma in von Hippel-Lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2. Endocrine Pathol 13:17–27CrossRefGoogle Scholar
  48. 48.
    Kopf D, Bockisch A, Steinert H, et al. (1997) Octreotide scintigraphy and catecholamine response to an octreotide challenge in malignant phaeochromocytoma. Clin Endocrinol 46:39–44CrossRefGoogle Scholar
  49. 49.
    Korf BR (2000) Malignancy in neurofibromatosis type 1. The Oncologist 5:477–485CrossRefPubMedGoogle Scholar
  50. 50.
    Lairmore TC, Ball DW, Baylin SB, et al. (1993) Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes. Ann Surg 217: 595–603PubMedGoogle Scholar
  51. 51.
    Lee JE, Curley SA, Gagel RF, et al. (1996) Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma. Surgery 120:1064–1071PubMedGoogle Scholar
  52. 52.
    Li FP, Fraumeni JF (1969) Soft-tissue sarcomas, breast cancer, and other neoplasms: a familial syndrome? Ann Int Med 71:747–752PubMedGoogle Scholar
  53. 53.
    Lips KJ, Van der Sluys Veer J, Struyvenberg A, et al. (1981) Bilateral occurrence of pheochromocytoma in patients with the multiple endocrine neoplasia syndrome type 2A (Sipple’s syndrome). Am J Med 70:1051–1060CrossRefPubMedGoogle Scholar
  54. 54.
    Maher ER, Iselius L, Yates JR, et al. (1991) Von Hippel-Lindau disease: a genetic study. J Med Genet 28:443–447PubMedGoogle Scholar
  55. 55.
    Malkin D, Jolly KW, Barbier N, et al. (1992) Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med 326:1309–1315PubMedGoogle Scholar
  56. 56.
    Marchesa P, Fazio VW, Church JM, et al. (1997) Adrenal masses in patients with familial adenomatous polyposis. Dis Colon Rectum 40:1023–1028CrossRefPubMedGoogle Scholar
  57. 57.
    Modigliani E, Vasen HM, Raue K, et al. (1995) Pheochromocytoma in multiple endocrine neoplasia type 2: European study. J Internal Med 238:363–367PubMedGoogle Scholar
  58. 58.
    Moley JF, Albinson C (2001) Medullary thyroid carcinoma and the multiple endocrine neoplasia type 2 syndromes. In: Doherty GM, Skogseid B (eds) Surgical endocrinology. Lippincott Williams & Wilkins, Philadelphia, pp 541–557Google Scholar
  59. 59.
    Mulligan LM, Kwok JB, Healey CS, et al. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458–460CrossRefPubMedGoogle Scholar
  60. 60.
    Nakamura H, Koga M, Higa S, et al. (1987) A case of von Recklinghausen’s disease associated with pheochromocytoma and papillary carcinoma of the thyroid gland. Endocrinol Jpn 34:545–551PubMedGoogle Scholar
  61. 61.
    Neumann HPH, Berger DP, Sigmund G, et al. (1993) Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N Engl J Med 329:1531–1538. [Erratum (1994) N Engl J Med 331:1535]CrossRefPubMedGoogle Scholar
  62. 62.
    Neumann HPH, Eng C, Mulligan LM, et al. (1995) Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia type 2. JAMA 274:1149–1151CrossRefPubMedGoogle Scholar
  63. 63.
    Neumann HPH, Bender BU, Reincke M, et al. (1999) Adrenal-sparing surgery for phaeochromocytoma. Br J Surg 86:94–97CrossRefPubMedGoogle Scholar
  64. 64.
    Neumann HPH, Bausch B, McWhinney SR, et al. (2002) Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346:1459–1466CrossRefPubMedGoogle Scholar
  65. 65.
    Neumann HPH, Hoegerle S, Manz T, et al. (2002) How many pathways to pheochromocytoma? Semin Nephrol 22:89–99CrossRefPubMedGoogle Scholar
  66. 66.
    Nguyen L, Niccoli-Sire P, Caron P, et al. (2001) Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study. Eur J Endocrinol 144:37–44CrossRefPubMedGoogle Scholar
  67. 67.
    Niemann S, Müller U (2000) Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 26:268–270CrossRefPubMedGoogle Scholar
  68. 68.
    O’Riordain DS, O’Brien T, Crotty TB, et al. (1995) Multiple endocrine neoplasia type 2B: more than an endocrine disorder. Surgery 118:936–942PubMedGoogle Scholar
  69. 69.
    Park VM, Pivnick EK (1998) Neurofibromatosis type 1 (NF1): A protein truncation assay yielding identification of mutations in 73% of patients. J Med Genet 35:813–820PubMedGoogle Scholar
  70. 70.
    Pomares FJ, Canas R, Rodriguez JM, et al. (1998) Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma. Clin Endocrinol 48:195–200Google Scholar
  71. 71.
    Ponder BA (1992) Neurofibromatosis: from gene to phenotype. Semin Cancer Biol 3:115–120PubMedGoogle Scholar
  72. 72.
    Richard S, Beigelman C, Duclos JM, et al. (1994) Pheochromocytoma as the first manifestation of von Hippel-Lindau disease. Surgery 116:1076–1081PubMedGoogle Scholar
  73. 73.
    Shulkin BL, Wieland DM, Schwaiger M, et al. (1992) PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma. J Nucl Med 33:1125–1131PubMedGoogle Scholar
  74. 74.
    Sims KB (2001) Von Hippel-Lindau disease: gene to bedside. Curr Opin Neurol 14:695–703CrossRefPubMedGoogle Scholar
  75. 75.
    Sipple JH (1961) The association of pheochromocytoma with carcinoma of the thyroid gland. Am J Med 31:163–166CrossRefGoogle Scholar
  76. 76.
    Sisson JC, Frager MS, Valk TW, et al. (1981) Scintigraphic localization of pheochromocytoma. N Engl J Med 305:12–17PubMedGoogle Scholar
  77. 77.
    Skogseid B, Larsson C, Lindgren PG, et al. (1992) Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 75:76–81CrossRefPubMedGoogle Scholar
  78. 78.
    Skogseid B, Rastad J, Gobl A, et al. (1995) Adrenal lesion in multiple endocrine neoplasia type 1. Surgery 118:1077–1082PubMedGoogle Scholar
  79. 79.
    Sköldberg F, Grimelius L, Woodward ER, et al. (1998) A family with hereditary extra-adrenal paragangliomas without evidence for mutations in the von Hippel-Lindau disease or ret genes. Clin Endocrinol 48:11–16CrossRefGoogle Scholar
  80. 80.
    Srivastava S, Zou Z, Pirollo K, et al. (1990) Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348:747–749PubMedGoogle Scholar
  81. 81.
    Stratakis CA (2001) Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes. J Endocrinol Invest 24:370–383PubMedGoogle Scholar
  82. 82.
    Stratakis CA, Kirschner LS, Carney JA (2001) Genetics of endocrine disease. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 86:4041–4046CrossRefPubMedGoogle Scholar
  83. 83.
    Taymans SE, Macrae CA, Casey M, et al. (1997) A refined genetic, radiation hybrid, and physical map of the Carney complex (CNC) locus on chromosome 2p16; evidence for genetic heterogeneity in the syndrome. Am J Hum Genet 61Suppl:A84Google Scholar
  84. 84.
    Tenenbaum F, Lumbroso J, Schlumberger M, et al. (1995) Comparison of radiolabeled octreotide and metaiodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. J Nucl Med 36:1–6PubMedGoogle Scholar
  85. 85.
    Thompson GB, Grant CS, van Heerden JA, et al. (1997) Laparoscopic versus open posterior adrenalectomy: a case-control study of 100 patients. Surgery 122:1132–1136CrossRefPubMedGoogle Scholar
  86. 86.
    Tibblin S, Dymling JF, Ingemansson S, et al. (1983) Unilateral versus bilateral adrenalectomy in multiple endocrine neoplasia IIA. World J Surg 7:201–208CrossRefPubMedGoogle Scholar
  87. 87.
    van Heerden JA, Sizemore GW, Carney JA, et al. (1984) Surgical management of the adrenal glands in the multiple endocrine neoplasia type II syndrome. World J Surg 8:612–621CrossRefPubMedGoogle Scholar
  88. 88.
    van Heerden JA, Sizemore GW, Carney JA, et al. (1985) Bilateral subtotal adrenal resection for bilateral pheochromocytomas in multiple endocrine neoplasia, type IIa: a case report. Surgery 98:363–365PubMedGoogle Scholar
  89. 89.
    Wagner J, Portwine C, Rabin K, et al. (1994) High frequency of germline p53 mutations in childhood adrenocortical cancer. J Natl Cancer Inst 86:1707–1710PubMedGoogle Scholar
  90. 90.
    Walther MM, Herring J, Enquist E, et al. (1999) Von Recklinghausen’s disease and pheochromocytomas. J Urol 162:1582–1586CrossRefPubMedGoogle Scholar
  91. 91.
    Walther MM, Reiter R, Keiser HR, et al. (1999) Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma. J Urol 162:659–664CrossRefPubMedGoogle Scholar
  92. 92.
    Walther MM, Herring J, Choyke PL, et al. (2000) Laparoscopic partial adrenalectomy in patients with hereditary forms of pheochromocytoma. J Urol 164:14–17CrossRefPubMedGoogle Scholar
  93. 93.
    Walther MM, Linehan WM, Libutti SK (2001) von Hippel-Lindau disease and von Recklinghausen’s disease. In: Doherty GM, Skogseid B (eds) Surgical endocrinology. Lippincott Williams & Wilkins, Philadelphia, pp 581–591Google Scholar
  94. 94.
    Walther MM (2002) New therapeutic and surgical approaches for sporadic and hereditary pheochromocytoma. Ann N Y Acad Sci 970:41–53PubMedGoogle Scholar
  95. 95.
    Walz MK, Peitgen K, Saller B, et al. (1998) Subtotal adrenalectomy by the posterior retroperitoneoscopic approach. World J Surg 22:621–627CrossRefPubMedGoogle Scholar
  96. 96.
    Wheeler MH, Curley IR, Williams ED (1986) The association of neurofibromatosis, pheochromocytoma, and somatostatin-rich duodenal carcinoid tumor. Surgery 100: 1163–1169PubMedGoogle Scholar
  97. 97.
    Wiedemann HR (1964) Complex malformatif familial avec hernie ombilicale et macroglossie — un syndrome nouveau? J Genet Hum 13:223–232PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Göran Åkerström
  • Per Hellman

There are no affiliations available

Personalised recommendations